Search

Showing 1 - 24 of 28 results

Previous| 1 | 2 |Next


IBS Diarrhea in Primary Care: Shorter Routes to Diagnosis and Symptom Assuagement Video

IBS Diarrhea in Primary Care: Shorter Routes to Diagnosis and Symptom Assuagement

Diarrhea related to irritable bowel syndrome is common, yet because it's a functional – not anatomical – disorder, providers frequently run more tests than necessary while patients worry and wait in discomfort.
Physician Referral Guide: Liver Tumor Clinic Document

Physician Referral Guide: Liver Tumor Clinic

THE UCSF LIVER TUMOR CLINIC provides specialized multidisciplinary care for patients with early- and intermediate-stage liver cancer and benign liver tumors.
Using AI to Improve Detection of Rare Diseases News

Using AI to Improve Detection of Rare Diseases

Acute hepatic porphyria (AHP) is a rare genetic disease with symptoms that overlap with many other conditions, making it extremely challenging to diagnose. Its symptoms mostly affect women with severe, sometimes life-threatening attacks that include abdominal pain, nausea, vomiting, limb weakness and anxiety.
Panel Issues First Guidelines to Prevent Anal Cancer in People With HIV News

Panel Issues First Guidelines to Prevent Anal Cancer in People With HIV

Results from a national study led by UC San Francisco informed the first guidelines at the federal level in the United States to detect and treat anal cancer precursor lesions in people with HIV to reduce the risk of developing anal cancer.
Can a New Drug Candidate Cure Pancreatic Cancer? News

Can a New Drug Candidate Cure Pancreatic Cancer?

UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition.
Can AI Predict Serious Adverse Events From IBD Therapies? News

Can AI Predict Serious Adverse Events From IBD Therapies?

In a groundbreaking study, UCSF researchers used a new clinical large language model (LLM) to identify serious adverse events (SAEs) occurring in patients treated with immunosuppressants to manage inflammatory bowel disease (IBD).
Navigate the New World of Genetic Testing: Tips and Tools for PCPs Video

Navigate the New World of Genetic Testing: Tips and Tools for PCPs

In this practical yet nuanced talk, gastroenterologist Aparajita Singh, MD, MPH, describes technological advances and dwindling barriers that are making tests for pathogenic gene variants more valuable and available than ever before.
Pain in the Butt: Tips on Diagnosing and Caring for Hemorrhoids and Fissures Video

Pain in the Butt: Tips on Diagnosing and Caring for Hemorrhoids and Fissures

Diana Ziser Rego, an adult-gerontology nurse practitioner with expertise in lower GI disorders, describes efficient routes to identifying hemorrhoids and anal fissures, offering tips on what questions to ask, straightforward management plans and guidance on when to refer.
Physician Survey Shows Lack of Understanding of the FDA’s Approval Process News

Physician Survey Shows Lack of Understanding of the FDA’s Approval Process

Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals are more rigorous than they are, according to a national survey of physicians conducted by researchers at UC San Francisco (UCSF). 
Robotically Assisted, Completely Minimally Invasive Whipple Surgery: Case Study With Video News

Robotically Assisted, Completely Minimally Invasive Whipple Surgery: Case Study With Video

Since performing San Francisco’s first pure robotically assisted Whipple procedure in 2022, UCSF surgeons continue to be on the forefront of this technology, regularly performing robotic Whipple surgeries (pancreatoduodenectomies) on select patients.
New Research on Optimizing UC Management Through Patient-Centered Tofacitinib Dosing News

New Research on Optimizing UC Management Through Patient-Centered Tofacitinib Dosing

Tofacitinib is effective for managing ulcerative colitis (UC) and is linked to sustained steroid-free remission. The product label recommends dose de-escalation after eight or 16 weeks, but is this best for patients?
There’s a More Humane Way to Monitor Crohn's and Colitis Patients News

There’s a More Humane Way to Monitor Crohn's and Colitis Patients

IBD, which comprises Crohn’s disease and ulcerative colitis, affects 1.3% of the U.S. population and accounts for 3 million new diagnoses every year.
First-line Pembrolizumab Plus Chemotherapy May Benefit Patients with Advanced Biliary Tract Cancers News

First-line Pembrolizumab Plus Chemotherapy May Benefit Patients with Advanced Biliary Tract Cancers

The addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untreated metastatic or unresectable biliary tract cancer, according to results from the phase III KEYNOTE-966 clinical trial.
Alcohol-Associated Liver Disease Program Document

Alcohol-Associated Liver Disease Program

UCSF HEPATOLOGY AND LIVER TRANSPLANT SERVICES have established the Alcohol-Associated Liver Disease Program, expanding access to hepatology care and liver transplantation for a broader range of patients.
Primary Care of the IBD Patient: Risk Factors, Symptoms and the Value of Timely Therapeutics Video

Primary Care of the IBD Patient: Risk Factors, Symptoms and the Value of Timely Therapeutics

In this update on inflammatory bowel disease, gastroenterologist Kendall Beck, MD, notes contributing causes, explains which tests have value, gives keys to distinguishing ulcerative colitis and Crohn’s...
Research Reveals Mechanisms at Work in Progression of Pancreatic Cysts to Pancreatic Cancer News

Research Reveals Mechanisms at Work in Progression of Pancreatic Cysts to Pancreatic Cancer

Tumor Immune Microenvironments May Provide Clues to Future Therapies
UCSF Develops First of Its Kind Robotic Surgery Trial in Partnership with FDA News

UCSF Develops First of Its Kind Robotic Surgery Trial in Partnership with FDA

UCSF Health is recruiting patients for the only FDA-approved study of the use of single port robotic technology for colorectal surgery in the United States.
Strategies for Reducing Length of Hospital Stay for Patients With Acute Severe Ulcerative Colitis News

Strategies for Reducing Length of Hospital Stay for Patients With Acute Severe Ulcerative Colitis

In a first-of-its-kind study, UCSF researchers assessed factors prolonging length of stay (LOS) for a diverse population of hospitalized patients with acute severe ulcerative colitis (ASUC) and identified interventions to reduce LOS for these patients.
The Evidence on Incidentalomas: When to Investigate, When to Rest Easy Video

The Evidence on Incidentalomas: When to Investigate, When to Rest Easy

This presentation from radiologist Hailey H. Choi, MD, supplies straightforward criteria to help providers assess lesions ranging from thyroid and adrenal nodules to ovarian cysts to pancreatic and liver lesions.
Genetic Gut Microbiome Variations Point to Precision Treatments for Metabolic Conditions News

Genetic Gut Microbiome Variations Point to Precision Treatments for Metabolic Conditions

In a new study, UCSF researchers found that the gut microbiome of East Asians is distinct from that of White individuals living in the same geographic region. This discovery may lead to personalized treatments for various metabolic conditions, including diabetes and obesity.
A Guide to GERD: Managing Symptoms and Complications of a Common Condition Video

A Guide to GERD: Managing Symptoms and Complications of a Common Condition

With gastroesophageal reflux disease affecting 40% of the U.S. population every month, primary care providers need a straightforward plan for initiating therapy, as well as an up-to-date understanding of causes and treatment complications.
Endoscopic Removal of Benign Complex Colorectal Lesions Improves Patient Outcomes News

Endoscopic Removal of Benign Complex Colorectal Lesions Improves Patient Outcomes

Endoscopic mucosal resection (EMR) is a safe and effective alternative to surgery for benign complex colorectal lesions, according to research led by UCSF gastroenterologist Tonya Kaltenbach, MD.
Liver Transplant Program and Referral Information Document

Liver Transplant Program and Referral Information

With more than 13,000 people in the United States with end-stage liver disease awaiting a liver transplant,UCSF has made liver transplantation services a high priority.
Manipulating Gut Microbiomes to Treat inflammatory Bowel Disease News

Manipulating Gut Microbiomes to Treat inflammatory Bowel Disease

Researchers at the Benioff Center for Microbiome Medicine at UCSF are working to accelerate understanding of how microbes promote health and prevent disease and to leverage this information to develop novel, effective treatments in the shortest possible time.

Showing 1 - 24 of 28 results

Previous| 1 | 2 |Next